NCT01892852

Acupuncture for Chemotherapy-induced Peripheral Neuropathy

Acupuncture Therapy for Chemotherapy-induced Peripheral Neuropathy in Lymphoma or Multiple Myeloma Patients: a Pilot Study

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 36 (estimated)
• Sponsor: Pusan National University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate whether acupuncture can be effective for chemotherapy-induced peripheral neuropathy in lymphoma or multiple myeloma patients.

Conditions

• Peripheral Neuropathy
• Toxicity Due to Chemotherapy
• Lymphoma
• Multiple Myeloma

Interventions

Type	Name	Description
PROCEDURE	Acupuncture	Acupuncture treatment will be performed by licensed doctors in Traditional Korean Medicine using 0.20 mm (diameter) X 0.40 mm (length) sized disposable acupuncture 3 times per week for 3 weeks. Acupuncture points are GV20, GB20 (bilateral), LI11 (bilateral), LI10 (bilateral), EX-UE9 (bilateral), ST36 (bilateral), ST40 (bilateral), and EX-LE10 (bilateral). Each session lasts 20-30 minutes.

Timeline

• Start date: 2013-06-01
• Primary completion: 2014-04-01
• Completion: 2014-04-01
• First posted: 2013-07-04
• Last updated: 2013-07-17

Locations

1 site across 1 country: South Korea